Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

ShedRx vs Vytora Health

ShedRx
Graded #3

Higher grade

vs+14.700000000000003
Vytora Health
Graded #79

Lower grade

The verdict

ShedRx takes it — 87/100 to 72.3/100.

ShedRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. The widest formulation spread on the board — injection, drops, lozenges and a daily oral pill, plus a real brand Zepbound lane.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueShedRx +25
84
59
Dose & formulationShedRx +11
96
85
Clinical oversightVytora Health +12
84
96
Labs & monitoringShedRx +29
84
55
FulfillmentVytora Health +8
88
96
Contract termsShedRx +65
85
20
ShedRx · left barVytora Health · right bar

The numbers

MetricShedRxVytora Health
WeighScore87/10072.3/100
GradeB+C
Scorecard rank#3#79
Semaglutide$199/mo$180/mo (all doses, compounded)
Tirzepatide$299/mo$249/mo (all doses, compounded)
CoverageAll 50 statesAll 50 states
Brand-name accessYesYes
Oral / sublingualYesInjection only
ShedRx

Graded #3 · B+

Strengths

  • Four GLP-1 routes — injection, liquid drops, lozenges and an oral daily pill
  • Brand Zepbound and Wegovy available beside the compounded line
  • Health coaching included with membership, plus a published 120-day weight-loss guarantee

Where it loses points

  • The advertised "as low as $239" tirzepatide rate requires a twelve-month commitment — month-to-month is $299
  • Compounded medication is not FDA-approved the way brand Ozempic, Wegovy, or Zepbound are
  • The dispensing compounding pharmacy is not publicly named
Vytora Health

Graded #79 · C

Strengths

  • All 50 states plus DC, with per-state video-vs-audio compliance disclosed
  • Both compounded and brand-name options on one platform — uncommon
  • LegitScript Approved and HIPAA compliant
  • Pharmacy partners named publicly: Vials Pharmacy (TX) and Greenwich Biosciences
  • Operating entity disclosed: Wasef Health, PC (Pinellas Park, FL)

Where it loses points

  • Brand-name Mounjaro/Zepbound at $1,399/mo is near retail — insured patients may do better via LillyDirect Self Pay ($449-$699/mo)
  • Compounded tirzepatide at $249/mo is mid-market, above the $149-199 floor
  • Dose tiers aren't broken out — 'all doses included' means low-dose patients pay the same as high-dose
  • Initial consultation cost not shown on the public pricing page
  • Limited per-prescriber state licensure detail

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard